The University of Chicago Header Logo

Connection

John Schneider to Diketopiperazines

This is a "connection" page, showing publications John Schneider has written about Diketopiperazines.
Connection Strength

0.060
  1. Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic. J Antimicrob Chemother. 2025 Nov 04; 80(11):3092-3100.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.